DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Cardene In 4.8% Dextrose In Plastic Container is a drug marketed by Chiesi and is included in one NDA. There are five patents protecting this drug and two Paragraph IV challenges.
This drug has twenty-three patent family members in eleven countries.
The generic ingredient in CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.
A generic version of CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER was approved as nicardipine hydrochloride by EPIC PHARMA on March 19th, 1998.
Summary for CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER
Recent Clinical Trials for CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
|National Institute of Neurological Disorders and Stroke (NINDS)||Phase 2|
|Vanderbilt University Medical Center||Phase 2|
|University of Zurich||Phase 4|
Pharmacology for CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER
Paragraph IV (Patent) Challenges for CARDENE IN 4.8% DEXTROSE IN PLASTIC CONTAINER
|Country||Patent Number||Estimated Expiration|
|Japan||S5545075||Try Before You Buy|
|Mexico||9203588||Try Before You Buy|
|Spain||543343||Try Before You Buy|
|South Korea||910003555||Try Before You Buy|
|Canada||1240930||Try Before You Buy|
|Japan||S60246313||Try Before You Buy|
|Israel||194799||Try Before You Buy|
|>Country||>Patent Number||>Estimated Expiration|